Rx · PZN 02524807, 02524813

QUILONUM retard tablets

German trade nameQUILONUM retardiert Tabletten

Active ingredientLithiumPharmaceutical formProlonged-release tablets

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Average purchase price (B2B)

~ €20

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

QUILONUM retard tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

QUILONUM retard tablets contains the active ingredient Lithium and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 9.6 out of 10 over the past 30 days.

Pack sizes · 2 PZN

PZN	Index 7 d	Index 30 d	Highest known purchase price
02524807	9.3	9.6	~ €12
02524813	9.4	9.6	~ €27

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.